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Introduction
Attention-deficit/hyperactivity disorder (ADHD) affects 
3 % of boys and 1 % of girls in the United Kingdom [1] 
and an estimated 5–7 % of children globally [2–4]. It is a 
risk factor for interpersonal and academic problems as well 
as higher rates of substance misuse and antisocial behavior; 
among adults, it predicts higher rates of driving violations, 
accidents, and injuries [5] as well as occupational impair-
ment. The economic burden of ADHD extends beyond 
health care to education, social services and youth justice 
services. The estimated annual total UK cost associated 
with social care and education providers’ resources for 
ADHD in adolescents is £670 million [6]. In the UK and 
globally, people with ADHD are most likely to seek ser-
vices from a pediatrician or general practitioner rather than 
a mental health specialist. This systemic issue may contrib-
ute to delayed diagnosis [7] and commencement of treat-
ment [8]. Early, accurate identification can improve out-
comes, while avoiding unnecessary medication exposure in 
those youths who do not have ADHD and would not likely 
benefit from the same interventions [9, 10]. However, sig-
nificant shortcomings in ADHD screening and diagnostic 
practices in primary care have been recognized [11]. The 
Strengths and Difficulties Questionnaire (SDQ) [12] was 
developed to be a brief, free-of-charge tool suitable for use 
in primary care and the general population. Studies have 
established its overall psychometric qualities [13, 14], and 
promising results for the identification of cases with ADHD 
in both community and clinical samples (see Table 1 for 
full list of citations and study details), with areas under the 
curve ranging from 0.77 to 0.97, reflecting a fair to excel-
lent diagnostic efficiency of the SDQ. However, these have 
generally relied on convenience samples, often with clinical 
diagnoses of ADHD, which typically show a kappa of 0.49 
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with research diagnoses [15] (a perfect agreement would 
equate to a kappa of 1, and chance agreement would equate 
to 0). ADHD rates also change with age and with gender 
[16], making age and sex norms important potential mod-
erators of test accuracy. Careful evaluation of the SDQ’s 
performance in a nationally representative sample, evaluat-
ing its ability to identify ADHD based on semi-structured 
diagnostic interviews diagnoses that integrate information 
about school functioning, consistent with current nosologi-
cal guidelines (DSM; ICD), is required.
The overarching goal of this study is to evaluate how 
the SDQ for Parents could help in the clinical identifica-
tion of ADHD conceptualized as a discrete category, dif-
ferentiating it from other sources of externalizing behav-
ior. To do this, we evaluated how the SDQ [12] performs 
for ADHD screening in a nationally representative sample 
of children and adolescents from the UK [1]. Although 
this is not the first study analyzing SDQ population data 
[17], it is the first direct comparison of the ability of mul-
tiple SDQ scales (Total difficulties, TD vs. Hyperactive/
inattention, H/I vs. Conduct problems, CD) for discrimi-
nating ADHD cases. We expected the parent SDQ TD 
and the H/I subscale to outperform other SDQ subscales 
for detecting any ADHD disorder. Due to the gender and 
age differences in the rates of symptoms, we also looked 
at whether these changed the accuracy of the SDQ with 
regard to ADHD status. It would be parsimonious if the 
scales showed consistent accuracy [18, 19] even though 
the mean scores might differ. If there were differences 
in accuracy, a nationally representative sample provides 
a good basis for establishing distinct sex or age-based 
norms. Finally, we followed the recommendations of evi-
dence-based medicine and facilitated clinical application 
of the SDQ by estimating multilevel diagnostic likelihood 
ratios (DLRs; [20]) for SDQ score ranges to ease clini-
cal application of the national norms to individual cases. 
DLRs are defined as the probability of a positive SDQ test 
result given ADHD divided by the probability of positive 
SDQ test result given non-ADHD.
Method
Participants and procedures
The current study used the data from The British Child and 
Adolescent Mental Health Survey 1999 [21], which was 
designed to estimate the prevalence rates based on Inter-
national Classification of Diseases-10 and DSM-IV crite-
ria. A total of 18,232 children and adolescent (5–15 years 
old) were recruited from England, Wales, and Scotland (see 
recruitment strategy details in [1]).
Trained child and adolescent psychiatrists reviewed both 
the verbatim accounts and the answers to the Development 
and Well-Being Assessment (DAWBA; see Measurement 
section for further detail) [22] before assigning diagnoses. 
All diagnoses used in this study were unmodified DSM-IV 
current rather than life-time diagnostic criteria.
Table 1  Summary of past studies reporting area under the curve for SDQ hyperactive/inattentive subscale
Com community sample, Clin clinical sample, AUC area under the curve, SE standard error
a Conduct and Hyperactivity were collapsed in a single group using DAWBA diagnoses
b The discriminant power of the SDQ H/I scale was judged by comparing all community subjects with those children who had been diagnosed 
by the DAWBA as having a conduct and hyperactivity disorder
c Formal diagnosis was determined by clinical diagnosis only
d ADHD rating scale-IV was used as a gold standard
e Samples matched by age and gender
f Comparisons were made between community sample vs. ADHD, excluding other diagnosis from comparison group
g Only p value is provided
Study citation N/ADHD Gender (% male) Age Source population (com, clin) Country AUC 95 % CI SE
[51] 27/59a
100/59b
55 5–12 Clin
Com/clin
Yemen 0.86
0.97
0.78–0.95
0.93–1.00
–
[33] 370/173c 73 5–17 Clin Germany 0.77 P < 0.001g –
[19] 240/283d 65 3–17 Clin Spain 0.86 0.82–0.89 –
[52] 47/47e – – Clin/com Shanghai/
China
0.77 0.71–0.83 –
[34] 110/65f
98/65
– 4–16 Com/clin
Clin
Germany 0.94
0.77
–
–
0.02
0.03
[53] 162/11c
88/11
– 4–16 Com/clin
Clin
Bangladesh 0.92
0.87
– 0.03
0.05
[18] 5997/236 50 7–9 Com Norway 0.91 0.90–0.92 –
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Parents, teachers, and eligible 11–15-year-old children 
were invited to complete the SDQ [12], a 25 item question-
naire divided between five scales of five items each (see 
details in Measurement section).
Measures
Development and Well‑Being Assessment (DAWBA; [22])
The DAWBA is a widely used semi-structured inter-
view that involves child and parent interviews alongside 
a teacher questionnaire. The child/parent interviews and 
teacher questionnaires assess current and recent past psy-
chiatric symptoms and their impact on functioning in chil-
dren. The DAWBA is based on diagnostic criteria (ICD-10 
and DSM-IV) and focuses on anxiety disorders, depressive 
disorders, ADHD and conduct disorders. A clinical diag-
nostic rating is informed by triangulation of these three 
sources.
The validity of the clinical diagnoses derived from the 
DAWBA have been demonstrated by concordance with 
case note screening in a clinical sample of children aged 
11–15 years [23], and with a full clinical assessment for 
ADHD specifically [24].
Strengths and Difficulties Questionnaire (SDQ; [12]): 
parent version
The 25-item SDQ generates scores for five subscales con-
firmed through factor analysis [25]: emotional problems, 
conduct problems, hyperactivity-inattention, peer prob-
lems, and prosocial behaviors. A total difficulties score 
also sums all items. The hyperactivity-inattention scale is 
composed by two items about inattention, two items about 
hyperactivity, and one item about impulsiveness—the three 
key symptom domains for a DSM-IV diagnosis of atten-
tion-deficit/hyperactive disorder (ADHD) [26]. The parent 
SDQ demonstrated good concordance with teacher and 
child versions, and good test–retest reliability and internal 
consistency [25]. Validity was demonstrated by predic-
tive validity and high specificity in terms of psychiatric 
diagnoses. Sensitivity was not as high. The present study 
focused on the global total difficulties score (TD), and the 
hyperactivity/inattention (H/I) and conduct problems (CP) 
subscales of the parent SDQ version as predictors of “any” 
DAWBA ADHD diagnosis.
Analytic plan
Nonparametric estimates of the area under the curve (AUC) 
from receiver operating characteristic (ROC) analyses 
quantified the diagnostic efficiency of the SDQ H/I, CD 
and TD subscale scores. A rough guideline for evaluating 
AUC values is: <0.70 poor, 0.70–0.79 fair; 0.80–0.89 good; 
and 0.90–1.00 excellent [27], although values higher than 
0.90 in mental health contexts are often the result of design 
flaws such as comparing clinical cases to healthy controls 
[28].
AUCs were calculated for the target condition of any 
ADHD using SDQ subscale scores, to evaluate whether 
the TD or subscales scores (H/I and CD) were better able 
to discriminate youth with any ADHD disorder from other 
youth in the sample. Venkatraman’s permutation test com-
pared ROC curves [29]. Moderator analyses tested whether 
the diagnostic efficiency for the SDQ subscale scores 
changed significantly when comparing males and females, 
and youth age groups.
Finally, we calculated diagnostic likelihood ratios 
(DLRs) for optimal cut-points yielding the best balance 
between sensitivity and specificity from the ROC curves 
[30]. DLRs based on optimal cut-points provide clinically 
useful information for predicting the likelihood of a diag-
nosis. DLRs of less than 1.0 indicate that the observed 
score is associated with lower odds; DLRs of 1.0 mean 
that the score does not change the odds; DLRs between 2 
and 5 are a small increase of the odds and potentially clini-
cally meaningful; DLRs between 5.0 and 10.0 are a moder-
ate increase, and DLRs greater than 10 are often clinically 
decisive [31].
All analyses were done using SPSS-Version 22.0 and 
pROC package in R [32].
Results
Demographics
Table 2 presents the participant demographics split by 
ADHD diagnosis. We report demographics for the ADHD 
combined group (n = 264) as well subgroups charac-
terized by inattention (n = 110) and by hyperactivity 
(n = 35). Mean age and family size did not differ signifi-
cantly across the groups. Half of the non-ADHD group 
was male, whereas this was significantly higher in each of 
the ADHD groups, comprising over 2/3 of the sample for 
each. Relative to the non-ADHD group, all three ADHD 
groups (combined, inattention and hyperactivity) had a sig-
nificantly higher percentage of white children, single parent 
family background, parental unemployment and mothers 
with no educational qualifications. The ADHD groups had 
also experienced three or more life events in the past year. 
For clinical variables, the ADHD groups reported poorer 
child and parent health and family functioning, as well as 
higher rates of neurodevelopmental problems.
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Diagnostic efficiency statistics
The AUCs for hyperactivity/inattention, conduct problems 
and total difficulties scales from the SDQ ranged from good 
(0.81) to excellent (0.96) in male and female subsamples 
and at different age ranges (Table 3a). Based on pairwise 
comparisons between paired AUCs between scales, H/I 
and TD outperformed the CP scale, except among males 
age 14–16 years. In the group of youngest males, H/I out-
performed TD, contrary to the result observed on females 
of the same age group, where TD outperformed H/I. With 
the exception of older males, as predicted, H/I and TD out-
performed the CP subscale for predicting any ADHD, and 
there were no major differences between H/I and TD per-
formance, in spite of the greater number of items of the TD 
subscale.
No significant AUC differences were found between gen-
der and age groups (p > 0.05) for the H/I subscale, supporting 
the use of a single set of cutoff scores for the entire sample.
A score of 5+ (from a possible range of 0–10) on the H/I 
subscale had a DLR of 2.3, and a score of 10 yielded a DLR 
of 21.3, reflecting a large increase in the post-test probability 
of any ADHD in this national community sample (Table 4).
An outpatient proxy clinical scenario: sensitivity 
analyses
As the sample composition of this national study could 
resemble the situation described by Youngstrom et al. [28], 
where high AUCs are the result of comparing a majority of 
healthy participants with a minority of clinical cases, sen-
sitivity analyses focused only on participants who received 
a positive mental health diagnosis other than any ADHD 
in The British Child and Adolescent Mental Health Survey 
1999 (e.g., n = 685 with any emotional diagnosis, n = 608 
with any anxiety diagnosis, n = 136 with less common 
psychiatric diagnosis, etc.). These evaluated the ability of 
the SDQ to discriminate “which diagnosis” instead of a 
general “sick versus well” comparison. The AUCs for H/I, 
CP and TD scales ranged from poor (<0.70) to good (0.88) 
(Table 3b). This time, when running pairwise comparisons 
between paired AUCs between subscales, H/I consistently 
outperformed CP and TD subscale. CP and TD perfor-
mance were fairly similar, showing a fair or poor perfor-
mance discriminating any ADHD in this subsample. As 
with the full sample, no significant moderating effect of age 
and gender was observed.
For the comparisons limited to clinical cases, a score of 
8+ (score range 0–10) in the H/I subscale produced a DLR 
of 1.8, and a score of 10 with a DLR of 4.47 (Table 4). 
Using an online calculator (http://araw.mede.uic.edu/cgi-
bin/testcalc.pl) to combine the information yields a precise 
estimate of 57 %, and using the probability nomogram rec-
ommended in EBM provides a close, quick approximation 
(Fig. 1).
AUCs observed in this subsample appear similar to 
benchmarks from other samples that used outpatient refer-
rals [19, 33, 34]; Table 1.
Table 2  Demographic and clinical information
*** p would be significant even after stringent Bonferroni correction
a Non-ADHD significantly different than ADHD groups
Non-ADHD 
(n = 18,007)
ADHD combined 
(n = 264)
ADHD inattentive 
(n = 110)
ADHD hyperactivity 
(n = 35)
Statistic F or chi 
square
Age, M ± SD 10.16 ± 3.27 10.02 ± 3.09 10.07 ± 2.81 9.32 ± 2.92 1.95
Gender, male [n (%)] 8987 (50) 224 (85) 83 (76) 29 (85) 170.8***
Race, white [n (%)] 16062 (89) 255 (97) 103 (94) 29 (85) 17.46**
Life events, 3 or more [yes (%)] 2267 (13) 75 (29) 28 (26) 11 (32) 82.09***
General health, bad [n (%)] 1133 (6) 46 (17) 14 (13) 4 (12) 59.93***
Neurodevelopmental problem 
[yes, n (%)]
526 (3) 46 (17) 23 (21) 3 (9) 285.15***
Mother edu qualification, none 
[yes (%)]
3688 (21) 90 (35) 22 (20) 8 (24) 29.80***
Parent working status, no work-
ing [yes (%)]
2991 (17) 89 (34) 27 (25) 10 (29) 61.94***
Family size, 3 or more children 
[yes, n (%)]
6324 (35) 87 (33) 48 (44) 15 (44) 5.24
Single parent family [yes, n (%)] 4126 (23) 104 (40) 36 (33) 9 (27) 46.01***
Family functioning score, 
M ± SD
1.69 ± .41a 1.92 ± 0.49 1.80 ± 0.48 1.90 ± 0.46 31.91***
Parent GHQ score, M ± SD 1.70 ± 2.70a 3.12 ± 3.32 2.96 ± 3.51 2.97 ± 3.12 33.35***
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Discussion
Results showed that the SDQ for Parents is a statistically 
valid tool for discriminating cases with ADHD from those 
without ADHD among a national representative group of 
youths, as well as from children experiencing other men-
tal health diagnoses in the UK. Accuracy levels were con-
sistent with SDQ performance discriminating psychopa-
thology reported by Stone’s review [35], and with details 
provided in Table 1. Also, present results add evidence to 
previous findings [17], because they are based on a nor-
mative sample, addressing sampling limitations in prior 
work.
Results from our sensitivity analysis, which focused 
only on participants with a positive mental health diagno-
sis, confirmed the SDQ as a valid tool to detect cases with 
ADHD among youths meeting criteria for other disorders. 
Again, prior studies established a plausible range of esti-
mates, and the present work advances clinical utility using 
a representative normative sample to establish weights, 
providing a good estimate of performance in pediatric and 
general practice settings.
We extended prior work by adding pairwise compari-
son between SDQ scales in this large community sample, 
testing performance of H/I, CD, and TD scales for identi-
fying any ADHD disorder. As hypothesized, the H/I and 
TD scales were significantly better than the CD subscale. 
It is notable that the H/I scale performed similarly to the 
TD despite its brevity. Furthermore, in line with previ-
ous reports, no significant differences in SDQ accuracy 
Table 3  SDQ AUC for whole 
sample (a) and SDQ AUC 
restricted to those with a 
positive psychiatric diagnosis–
sensitivity analyses (b)
Venkatraman’s test for two paired ROC curves (n bootstrap replications = 2000). Superscript letters repre-
sent pairwise significantly different ROC comparisons (p < 0.05). Note that Venkatraman’s test compares 
the entire curves, so it can detect overall differences in performance even when confidence intervals for 
point estimates overlap
¥ Significant (p < 0.05) Venkatraman’s test for two unpaired ROC curves (H/I subscale male vs. female)
a H/I > CD
b H/I > TD
c CP < TD
d H/I < TD
AUC [95 % CI]
SDQ scales parent version Age < 10 11–13 14–16
(a)
Male any ADHD/non-ADHD, n 184/4725 96/2417 55/1762
 Hyperactivity/inattention 0.92 [0.91–0.94]a,b 0.92 [0.91–0.94]a 0.91 [0.89–0.94]
 Conduct problems 0.81 [0.77–0.84]c 0.85 [0.81–0.89]c 0.88 [0.83–0.92]
 Total difficulties 0.90 [0.89–0.92] 0.92 [0.90–0.94] 0.91 [0.88–0.94]
Female any ADHD/non-ADHD, n 39/4827 21/2317 12/1769
 Hyperactivity/inattention 0.92 [0.88–0.97]a,d 0.93 [0.87–0.99]a 0.96 [0.94–0.99]a
 Conduct problems 0.82 [0.75–0.90]c 0.83 [0.73–0.93]c 0.86 [0.77–0.95]c
 Total difficulties 0.93 [0.91–0.95] 0.92 [0.85–0.98] 0.94 [0.89–0.99]
(b)
Male any ADHD/non-ADHD, n 184/330 96/209 55/184
 Hyperactivity/inattention 0.76 [0.72–0.80]a,b,¥ 0.78 [0.73–0.83]a,b 0.75 [0.68–0.82]a,b
 Conduct problems 0.57 [0.52–0.62]c 0.63 [0.56–0.70] 0.65 [0.57–0.73]
 Total difficulties 0.63 [0.58–0.68] 0.65 [0.59–0.72] 0.68 [0.60–0.75]
Female any ADHD/non-ADHD, n 39/233 21/170 12/198
 Hyperactivity/inattention 0.78 [0.70–0.85]a,b 0.80 [0.70–0.90]a 0.88 [0.80–0.95]a
 Conduct problems 0.61 [0.52–0.71] 0.63 [0.49–0.76] 0.66 [0.49–0.83]
 Total difficulties 0.64 [0.56–0.72] 0.70 [0.57–0.83] 0.77 [0.61–0.93]
Table 4  Diagnostic likelihood ratio of the SDQ I/H subscale
Hyperactivity/inattention scale score 
range
Full sample, Any ADHD prevalence (2 %)
0–4 5–9 10
 Diagnostic likelihood ratio 0.03 2.34 21.32
Subsample with + diagnostic, any ADHD prevalence (23 %)
0–4 5–7 8–9 10
 Diagnostic likelihood ratio 0.06 0.77 1.80 4.47
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between males and females were observed [18, 19], nor did 
accuracy differ between age groups [19].
Evidence-based assessment is an important compo-
nent of the diagnosis and treatment of mental health 
problems. It can help clinicians to improve the accuracy 
of their diagnostic decisions and limit the influence of 
the bias and heuristics on clinical judgment [36]. Incor-
porating actuarial methods as part of the assessment pro-
cess enables clinicians to integrate multiple sources of 
data, improving the specificity of predictions made about 
diagnosis and prognosis [37–39]. The SDQ discriminates 
cases with any ADHD disorders from those with other 
disorders (as observed in sensitivity analyses), showing 
its utility as a component of the assessment process. The 
current study adds to the data indicating that, in addi-
tion to identifying youth with ADHD in a representa-
tive national community sample, the SDQ can also help 
to identify youth with ADHD in clinical samples. This is 
important, as the ability to distinguish healthy youth from 
youth with ADHD is not as helpful as being able to distin-
guish youth with ADHD from youth with ODD or other 
externalizing symptoms. It is also one of the first studies 
to provide nationally representative norms and weights, 
combined with a semi-structured diagnostic interview to 
provide the criterion diagnosis. In addition to being the 
largest study to date, the present work also used state–of-
the-art analytic methods to evaluate potential moderators 
of accuracy. It is also the first to present DLRs, which are 
crucial for clinicians to integrate the SDQ into the evi-
dence-based assessment framework, integrating clinical 
findings in a way that directly guides decision-making for 
individual cases.
As an example, using McGee’s mnemonic [40], a like-
lihood ratio of 4 increases the probability of any ADHD 
by about 25 %. For example, with a pretest probability 
of 23 % (estimated prevalence of any ADHD in this sub-
sample of youths), and a cutoff score of 10 in the H/I sub-
scale, the post-test probability of having any ADHD would 
23 + 25 = 48 %, fairly close to the more precise estimate 
of 57 % obtained using a probability nomogram or calcu-
lator (http://araw.mede.uic.edu/cgi-bin/testcalc.pl) to apply 
Bayes’ Theorem.
Limitations
Though the SDQ has clear clinical utility, the subsam-
ples of youth with ADHD subtypes diagnosis (particu-
larly hyperactivity, n = 35) limited our ability to test SDQ 
performance between ADHD subtypes. Although SDQ 
Teacher data were gathered, teacher ratings were used as a 
piece of evidence in establishing the formal diagnosis using 
the DAWBA; thus there would be criterion contamination 
that would exaggerate the apparent accuracy of teacher 
report because it contributed to both the predictor and the 
criterion [41]. Future studies of the SDQ in community 
samples should evaluate both measures in a design that 
avoids criterion contamination to explore whether one out 
performs the other and whether there is incremental valid-
ity in combining the two [42, 43]. In this study, ADHD is 
conceptualized as a discrete category, an assumption that 
would be inconsistent with a dimensional conceptualiza-
tion of ADHD. But, even when many aspects of a construct 
behave continuously, there are practical reasons to specify 
Fig. 1  Probability Nomogram using SDQ I/H subscale. Instructions 
to use a nomogram: Step 1 indicates the pretest probability or esti-
mated prevalence of a particular condition (23 % of any ADHD in 
this example). Step 2 in the middle axis, carries information about 
the associated diagnostic likelihood ratio with a particular cut score 
(based on Table 4, a DLR of 4.47 is associated with a score of 10). 
Finally, Step 3 reflects the estimate post-test probability of having 
any ADHD diagnosis. If a different youth obtains a different score in 
the SDQ I/H subscale, for example a score of 8, the only correction 
needed to previous steps is the identification of the appropriate DLR 
in Table 4. Next, trace a new line starting at the same point (identical 
estimated prevalence), crossing the appropriate DLR as a Step 2, and 
reading the new estimated post-test probability in the last axis (see 
thin arrow)
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thresholds for dichotomous present/absent or treat/do not 
treat decisions. This is well established with both hyperten-
sion and obesity—the distribution of these is not bimodal, 
but thresholds are used for labeling and for treatment deci-
sions [44].
Finally, ADHD can be conceptualized either as a source 
of group differences or as a constructivist variable. We 
note that even a constructivist definition of ADHD also 
has issues of reliability and measurement error. For exam-
ple, patients could misread a checklist, or misconstrue the 
nature of the item. Clinicians frequently interpret the same 
responses differently—multiple studies have shown that 
even when presented with videotaped interviews [45] or 
vignettes with fixed content [46–48], clinicians apply the 
constructivist definitions inconsistently. Patients confront 
this regularly when they get a second opinion: One phy-
sician says “yes,” and the other says, “no”… so does the 
person have the illness or not? Kraemer [30] talked about 
this as resulting in imperfect reliability and validity for the 
diagnostic criterion, and the medical testing literature has 
developed methods for dealing with missing or imperfect 
gold standards [49, 50], recognizing that error can influ-
ence even categorical conditions with strong biological 
models.
The SDQ is a free, easy-to-use measure that has dem-
onstrated utility as an ADHD disorder screening meas-
ure in community, and between youth experiencing men-
tal health problems in the community in the UK. Current 
results suggest that elevated scores on the subscales of the 
SDQ increase the likelihood that an individual meets crite-
ria for any ADHD, by a factor of more than 20 compared 
to healthy peers, and by a factor of 4.5 compared to other 
youths with commonly diagnosed mental health issues (as 
reflected by DLR in Table 4). From a clinician’s perspec-
tive, this information can be very helpful in determining 
whether further assessment and/or treatment is warranted 
as well as informing selection between treatments.
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